An S, Zhang Y, Tang YD, Askari B, Gerdes AM. BNP as a New Biomarker of Cardiac Thyroid Hormone Function. Front Physiol. 2020;11:729. \[[PMC free article: PMC7363952](/pmc/articles/PMC7363952/)\] \[[PubMed: 32733267](https://pubmed.ncbi.nlm.nih.gov/32733267)\] 54. Francis GS, Felker GM, Tang WH. A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure. J Am Coll Cardiol. 2016 Jan 26;67(3):330-7. \[[PMC free article: PMC4928678](/pmc/articles/PMC4928678/)\] \[[PubMed: 26796399](https://pubmed.ncbi.nlm.nih.gov/26796399)\] 55. Seino Y, Ogawa A, Yamashita T, Fukushima M, Ogata K, Fukumoto H, Takano T. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail. 2004 Mar 15;6(3):295-300. \[[PubMed: 14987579](https://pubmed.ncbi.nlm.nih.gov/14987579)\] 56. Savarese G, Musella F, D'Amore C, Vassallo E, Losco T, Gambardella F, Cecere M, Petraglia L, Pagano G, Fimiani L, Rengo G, Leosco D, Trimarco B, Perrone-Filardi P. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis. JACC Heart Fail. 2014 Apr;2(2):148-58. \[[PubMed: 24720923](https://pubmed.ncbi.nlm.nih.gov/24720923)\] 57. Kelly R, Struthers AD. Are natriuretic peptides clinically useful as markers of heart failure? Ann Clin Biochem. 2001 Sep;38(Pt 5):575-83. \[[PubMed: 11587142](https://pubmed.ncbi.nlm.nih.gov/11587142)\] 58. Nishikimi T, Nakagawa Y. Potential pitfalls when interpreting plasma BNP levels in heart failure practice. J Cardiol. 2021 Oct;78(4):269-274. \[[PubMed: 34088563](https://pubmed.ncbi.nlm.nih.gov/34088563)\] 59. Badrick T. The quality control system. Clin Biochem Rev. 2008 Aug;29 Suppl 1(Suppl 1):S67-70. \[[PMC free article: PMC2556587](/pmc/articles/PMC2556587/)\] \[[PubMed: 18852861](https://pubmed.ncbi.nlm.nih.gov/18852861)\] 60. Bruno LC. IQCP: Guideline and Helpful Tools for Implementation. Lab Med. 2016 Nov;47(4):e42-e46. \[[PubMed: 27708173](https://pubmed.ncbi.nlm.nih.gov/27708173)\] 61. Westgard JO, Westgard SA. Establishing Evidence-Based Statistical Quality Control Practices. Am J Clin Pathol. 2019 Mar 01;151(4):364-370. \[[PubMed: 30517600](https://pubmed.ncbi.nlm.nih.gov/30517600)\] 62. Cornish NE, Anderson NL, Arambula DG, Arduino MJ, Bryan A, Burton NC, Chen B, Dickson BA, Giri JG, Griffith NK, Pentella MA, Salerno RM, Sandhu P, Snyder JW, Tormey CA, Wagar EA, Weirich EG, Campbell S. Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future. Clin Microbiol Rev. 2021 Jun 16;34(3):e0012618. \[[PMC free article: PMC8262806](/pmc/articles/PMC8262806/)\] \[[PubMed: 34105993](https://pubmed.ncbi.nlm.nih.gov/34105993)\] 63. Pentella MA. Update on Biosafety and Emerging Infections for the Clinical Microbiology Laboratory. Clin Lab Med. 2020 Dec;40(4):473-482. \[[PubMed: 33121616](https://pubmed.ncbi.nlm.nih.gov/33121616)\] **Disclosure:** Madeline Novack declares no relevant financial relationships with ineligible companies. **Disclosure:** Muhammad Zubair declares no relevant financial relationships with ineligible companies.